Delivery Order SPE2DB20D1109-SPE2DB23FN75B
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,931.70 firm fixed-price delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,961.38 delivery order contract is for the supply of Brilinta 90 mg tablets, a cardiovascular medication. The contract has a firm fixed price pricing type and a completion date of November 16, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,680.55 Firm Fixed Price Delivery Order is for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The award has an ultimate completion date of January 26, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,069.60 for the pharmaceutical product BRILINTA 90 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4557297095 BRILINTA 90 MG TABLET 60S. The $1,720.23 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on May 19, 2022, with a completion date of May 20, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of BRILINTA 60 MG TABLET 60S. The $1,086.68 firm fixed-price delivery order has a completion date of July 27, 2023 and was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,289.83, is for the delivery of 4562494171 BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,756.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of BRILINTA 90 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of February 9, 2024. The contract is a Firm Fixed Price agreement and was awarded on February 8, 2024, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,343.98 for the supply of BRILINTA 60 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a performance period ending on September 20, 2022. The contract type is Firm Fixed Price, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,438.82 for the supply of BRILINTA 60 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD) that procures medical supplies and pharmaceuticals for military and veterans' healthcare programs. The contract is a firm fixed-price arrangement and was not designated as a set-aside for specific business types....
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN75BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $2,206.07 delivery order is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a firm fixed price and is set to be completed by March 20, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable the efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 3/17/23 |